Earnings Per Share
EPS (Diluted)
Guardant Health EPS (Diluted) increased by 15.0% to $-0.85 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 10.4%, from $-0.77 to $-0.85. Over 4 years (FY 2021 to FY 2025), EPS (Diluted) shows an upward trend with a -4.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementIncome Statement
SectionEarnings Per Share
CategoryProfitability
SignalHigher is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ1 2026May 7, 2026
How to read this metric
Higher values indicate stronger per-share profitability even after accounting for potential dilution.
Detailed definition
Diluted earnings per share accounts for the potential impact of all dilutive securities, such as stock options, warrants...
Peer comparison
Standardized metric that is always equal to or lower than basic EPS, used for conservative valuation.
Metric ID:
eps_dilutedHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$0.96 | -$1.06 | -$0.89 | -$1.21 | -$2.25 | -$1.58 | -$1.37 | -$1.30 | -$0.67 | -$0.73 | -$1.62 | -$0.94 | -$0.84 | -$0.88 | -$0.90 | -$0.77 | -$0.80 | -$0.74 | -$1.00 | -$0.85 |
| QoQ Change | — | -10.4% | +16.0% | -36.0% | -86.0% | +29.8% | +13.3% | +5.1% | +48.5% | -9.0% | -121.9% | +42.0% | +10.6% | -4.8% | -2.3% | +14.4% | -3.9% | +7.5% | -35.1% | +15.0% |
| YoY Change | — | — | — | — | -134.4% | -49.1% | -53.9% | -7.4% | +70.2% | +53.8% | -18.2% | +27.7% | -25.4% | -20.5% | +44.4% | +18.1% | +4.8% | +15.9% | -11.1% | -10.4% |
Range-$2.25 – -$0.67
CAGR-2.5%
Avg YoY Growth-6.0%
Median YoY Growth-8.9%
EPS (Diluted) at Other Companies
Frequently Asked Questions
- What is Guardant Health's eps (diluted)?
- Guardant Health (GH) reported eps (diluted) of $-0.85 in Q1 2026.
- How has Guardant Health's eps (diluted) changed year-over-year?
- Guardant Health's eps (diluted) decreased by 10.4% year-over-year, from $-0.77 to $-0.85.
- What is the long-term trend for Guardant Health's eps (diluted)?
- Over 4 years (2021 to 2025), Guardant Health's eps (diluted) has grown at a -4.6% compound annual growth rate (CAGR), from $-4.00 to $-3.31.
- What does eps (diluted) mean?
- The profit per share assuming all convertible securities are exercised or converted into common stock.